Stem Cell Transplantation

Light-chain (AL) amyloidosis is a systemic syndrome characterized by progressive organ dysfunction leading to organ failure and death. The heart is the most…

Background/Aims: The present Bayesian network meta-analysis (NMA) was to compare the efficacy of different chemotherapies and autologous stem cell transplantation (…

Rationale: Immunoglobulin light chain amyloidosis (AL amyloidosis) is characterized by the deposition of abnormal amyloid protein produced by a pathological plasma…

Systemic light-chain (AL) amyloidosis is an infiltrative disorder associated with an underlying plasma cells dyscrasia, in which monoclonal immunoglobulin light…

Amyloidosis is a rare disease caused by extracellular deposition of proteins in an insoluble beta-pleated physical conformation. Multiple causative proteins have…

In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits, derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia,…

Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…

Dr. Surbhi Sidana is an Assistant professor of medicine in the division of blood & marrow transplantation at the Stanford University Medical Center. She…

Maurizio Zangari is a Professor of Medicine at Myeloma Center of University of Arkansas for Medical Sciencesexternal link, opens in a new tab. Dr. Zangari trained…